Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight

globenewswire.com
TMO Mentioned as a parent company of Patheon, a CDMO, within the context of the biosimulation market report. No specific sentiment towards Thermo Fisher Scientific itself. PFE Mentioned in relation to its CDMO division (Pfizer CenterOne) and as a key player in Biologics Drug Substance Manufacturing and Biopharmaceuticals Contract Manufacturing, within a biosimulation market report. No direct sentiment. AMGN While Amgen is a major player in biopharmaceuticals, it is not explicitly mentioned in the article. The article discusses the biosimulation market and lists other companies involved in CDMO and manufacturing services. ABBV Mentioned as a key player in Biologics Contract Manufacturing and Biopharmaceuticals Contract Manufacturing, within the context of a biosimulation market report. No specific sentiment expressed.

Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight New York, USA, April 27, 2026 (GLOBE NEWSWIRE) -- Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight

The biosimulation market is witnessing robust expansion, fueled by the increasing adoption of model-informed drug development (MIDD), the growing complexity of modern drug development, and the rising emphasis on personalized and precision medicine. MIDD strategies allow pharmaceutical companies to leverage advanced computational models to forecast drug behavior, refine dosing strategies, and minimize dependence on expensive clinical trials, ultimately speeding up development timelines.

DelveInsight’s Biosimulation Market Insights report provides the current and forecast market analysis, individual leading biosimulation companies’ market shares, challenges, biosimulation market drivers, barriers, trends, and key biosimulation companies in the market.

Biosimulation Market Summary

To read more about the latest highlights related to the biosimulation market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/biosimulation-market

Key Factors Contributing to the Rise in Growth of the Biosimulation Market

Get a sneak peek at the biosimulation market dynamics @ Biosimulation Market Trends

Regional Biosimulation Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the biosimulation market, get a snapshot of the Biosimulation Market Share

Recent Developmental Activities in the Biosimulation Market

What is Biosimulation?

Biosimulation is the use of advanced computer-based modeling and simulation techniques to predict how biological systems and drug candidates behave in the human body. It combines data from biology, pharmacology, physiology, and clinical studies to create virtual models that can estimate a drug’s absorption, distribution, metabolism, efficacy, safety, and potential outcomes across different patient populations. Widely used in pharmaceutical and biotechnology industries, biosimulation supports decision-making throughout drug development by optimizing dose selection, reducing trial risks, improving study design, and accelerating timelines while lowering costs. Common applications include physiologically based pharmacokinetic (PBPK) modeling, population pharmacokinetic/pharmacodynamic (PK/PD) analysis, and disease progression modeling, making biosimulation a critical tool in modern precision medicine and regulatory science.

Biosimulation Market Assessment

Which MedTech key players in the biosimulation market are set to emerge as the trendsetter explore @ Biosimulation Market Analysis

Table of Contents

Interested in knowing the biosimulation market share by 2034? Click to get a snapshot of the Biosimulation Market Size

Related Reports

Contract Development Manufacturing Organization Market

Contract Development Manufacturing Organization Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key CDMO companies, including Patheon (Thermo Fisher Scientific), Catalent,Inc, Laboratoire Elaiapharm, The Lubrizol Corporation, Cambrex Corporation, Recipharm (EQT), Merck & Co., Inc, AGC Biologics, Nerpharma S.r.l, Pfizer CenterOne (Pfizer Inc), EMERGENT, Onyx Scientific Limited, Lonza, Siegfried Holding AG, CordenPharma International, FUJIFILM Diosynth Biotechnologies, Samsung Biologics, Delpharm, Center for Breakthrough Medicines, and WuXi Biologics, and others.

Biopharmaceuticals Contract Manufacturing Market

Biopharmaceuticals Contract Manufacturing Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key biopharmaceuticals contract manufacturing companies, including Boehringer Ingelheim International GmbH, Lonza, Rentschler Biopharma SE, BINEX Co., Ltd., INCOG BioPharma Service, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Novartis AG, ProBioGen AG, TOYOBO CO., LTD., Samsung Biologics, Thermo Fisher Scientific, Inc., AbbVie, Inc., WuXi Biologics, AGC Biologics, ADMA Biologics, Inc., Baxter BioPharma Solutions (Baxter), iBio., Catalent, Inc., Cambrex Corporation, Pfizer Inc., and others.

Biologics Drug Substance Fill and Finish Manufacturing Market

Biologics Drug Substance Fill and Finish Manufacturing Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key biologics drug substance fill and finish manufacturing companies, including JOINN Biologics, Pharmaron, Symbiosis Pharmaceutical Services, AGC Biologics, INCOG BioPharma Services, CPC, Eurofins Scientific, and others.

Biologics Drug Substance Manufacturing Market

Biologics Drug Substance Manufacturing Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key biologics drug substance manufacturing companies, including Lonza, Pfizer Inc., Catalent, Inc., Boehringer Ingelheim International GmbH, Samsung Biologics, WuXi AppTec, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Recipharm AB, Evotec, Novo Nordisk A/S, Siegfried Holding AG, Enzene Biosciences Ltd., Forge Biologics, BeiGene LTD., FUJIFILM Holdings Corporation, TOYOBO CO., LTD., AJINOMOTO CO., INC., Biocon, Eurofins Scientific, and others.

Biologics Contract Manufacturing Market

Biologics Contract Manufacturing Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key biologics contract manufacturing companies, including Boehringer Ingelheim, Catalent, Lonza, WuXi Biologics, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, AbbVie, AGC Biologics, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.